Acinetobacter baumannii cytoplasmic membrane

The Acinetobacter baumannii cytoplasmic membrane is the inner plasma membrane of this Gram-negative opportunistic pathogen, separating the cytoplasm from the periplasm and playing essential roles in nutrient transport, energy generation, and cell integrity.[1][2] Unlike the well-studied outer membrane, which features porins like OmpA (outer membrane protein A) that contribute to low permeability and antibiotic resistance, the cytoplasmic membrane is not typically referenced as a distinct therapeutic target in literature.[2][3][5] A. baumannii, a major nosocomial pathogen, relies on its dual-membrane system for multidrug resistance, including beta-lactamase activity and efflux, but drugs primarily target outer membrane components, enzymes, or cell wall synthesis rather than the cytoplasmic membrane directly.[1][2] No specific drugs or mechanisms are documented to selectively interact with the cytoplasmic membrane, and its broad nature as a cellular compartment precludes it from being a precise druggable target.[2][5] In infections, disrupting bacterial membranes generally (e.g., via polymyxins) raises toxicity concerns in human cells, limiting therapeutic exploitation.[1] Overall, while integral to bacterial survival and pathogenesis in ventilator-associated pneumonia and bloodstream infections, the cytoplasmic membrane lacks validated roles as a receptor, enzyme, or specific target for intervention.[1][2][3] ## Explanation The provided query name "Acinetobacter baumannii cytoplasmic membrane" refers to a general cellular structure (the inner membrane) rather than a specific protein, receptor, enzyme, or discrete target, making it incorrect and non-targetable in standard pharmacological contexts.[1][2] Reliable sources emphasize the **outer membrane** (e.g., OmpA as the primary porin for permeability and resistance) over the cytoplasmic one.[2][3][5] No canonical abbreviation, aliases, drugs, or biomarkers are associated, as it's not a molecular entity like proteins (e.g., OmpA, YiaD, CarO).[3][5][6] Classifications and functions are inferred from Gram-negative membrane biology, with disease relevance tied to A. baumannii infections (ESKAPE pathogen).[1][7] Search results yielded no direct hits for cytoplasmic membrane targeting, confirming its non-specific status.[1][2]